Additionally, VE-Cadherin and FGFR1 levels were reduced in DCKO tumors compared to control tumors, reflective of reduced tumor angiogenesis and tumor endothelial Fgfr1 deletion (Supplementary Fig. S2A). The gene discussed is CDH5; the disease is neoplasm.